Company intelligence / Profile preview
Pharmazac S.A.
- Ownership
- Private
- Employees
- ~95
- Development stage
- Commercial
Overview
Pharmazac is a leading Greek pharmaceutical company specializing in the development, manufacturing, marketing, and export of high-quality generic medicines. The company has established itself as a reliable partner for multinational firms and has expanded its own product portfolio with more than 100 licensed brands in Greece. Its pipeline includes over 15 new products under development as of recent years. Pharmazac operates GMP-certified facilities and is investing further in pharmaceutical and radio-pharmaceutical manufacturing capacity. It maintains strategic partnerships with major global companies such as Takeda, GE Healthcare, and Sandoz[3][5][6].
- Therapeutic areas
- CardiovascularEndocrinology
- Modalities
- Small molecules (generics)Radio-pharmaceuticalsFood supplements
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Pharmazac S.A..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharmazac S.A..